At what age is the human papillomavirus vaccine administered?

The human papillomavirus (HPV) vaccine is recommended to be administered around the age of 12 years. This timing is critical because vaccination at this age provides the best chance of developing immunity before potential exposure to the virus, which is most commonly transmitted through sexual contact. The vaccine is particularly effective in preteens and adolescents, before they become sexually active.

The vaccination program is designed to protect individuals from HPV-related diseases, including cervical cancer and other HPV-associated cancers. By immunizing children at the age of 12, health authorities aim to maximize public health outcomes and reduce the incidence of these diseases in the population.

While the vaccine can be given at earlier ages (such as 11) or later (up to the age of 26), starting the vaccination schedule at 12 years aligns with the ideal timing for optimal effectiveness and is the age most widely recommended by health organizations.